Newswise — QuantiScientifics A2 (A-squared) Multiplex Immunoassay permits the simultaneously measure of numerous clinically relevant protein analytes all within the same sample in each well of a specially designed 96 well microtiter plate. The A2 (A-squared) technology utilizes DNA scaffolding to self-assemble antibodies or antigens to create multiplex immunoassays.
QuantiScientifics in collaboration with BioDot, Inc. offers the A2DxA System for automated dispensing, processing and analysis of multiplex ELISAs based upon the A2 Technology. Dr. Robert Matson, President of QuantiScientifics will discuss the advantages of oligonucleotide tethering that enables the creation of quantitative multiplex bioassays in 2.5 days!
RSS